You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 17, 2024

sotalol hydrochloride Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Sotalol Hydrochloride patents expire, and what generic alternatives are available?

Sotalol Hydrochloride is a drug marketed by Altathera Pharms Llc, Apotex, Aurobindo Pharma Usa, Beximco Pharms Usa, Epic Pharma Llc, Impax Pharms, Natco Pharma Usa, Oxford Pharms, Rising, Sun Pharm Industries, Teva, Upsher Smith Labs, and Watson Labs. and is included in seventeen NDAs. There are four patents protecting this drug.

The generic ingredient in SOTALOL HYDROCHLORIDE is sotalol hydrochloride. There are ten drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the sotalol hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Sotalol Hydrochloride

A generic version of sotalol hydrochloride was approved as sotalol hydrochloride by TEVA on May 1st, 2000.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for sotalol hydrochloride?
  • What are the global sales for sotalol hydrochloride?
  • What is Average Wholesale Price for sotalol hydrochloride?
Drug patent expirations by year for sotalol hydrochloride
Recent Clinical Trials for sotalol hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rush University Medical CenterN/A
HagaZiekenhuisPhase 2/Phase 3
Abant Izzet Baysal UniversityN/A

See all sotalol hydrochloride clinical trials

Pharmacology for sotalol hydrochloride
Drug ClassAntiarrhythmic
Mechanism of ActionAdrenergic beta-Antagonists
Physiological EffectCardiac Rhythm Alteration
Medical Subject Heading (MeSH) Categories for sotalol hydrochloride
Anatomical Therapeutic Chemical (ATC) Classes for sotalol hydrochloride

US Patents and Regulatory Information for sotalol hydrochloride

sotalol hydrochloride is protected by six US patents.

Patents protecting sotalol hydrochloride

Method of initiating and escalating sotalol hydrochloride dosing
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: DOSING REGIMEN FOR INTRAVENOUS SOTALOL FOR ADMINISTRATION IN A FACILITY THAT CAN PROVIDE CONTINUOUS ELECTROCARDIOGRAPHIC MONITORING AND CARDIAC RESUSCITATION.

Method of initiating and escalating sotalol hydrochloride dosing
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: INTRAVENOUS SOTALOL DOSING REGIMEN FOR ACHIEVING STEADY STATE EXPOSURE IN A FACILITY THAT CAN PROVIDE ELECTROCARDIOGRAPHIC MONITORING

Method of administering sotalol IV/switch
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: INTRAVENOUS SOTALOL DOSING REGIMEN FOR USE IN A FACILITY THAT CAN PROVIDE ELECTROCARDIOGRAPHIC MONITORING

Method of administering sotalol IV/switch
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: USE FOR LOADING DOSE IN PATIENTS WITH SYMPTOMATIC AFIB/AFL WHO ARE CURRENTLY IN SINUS RHYTHM OR FOR THE TREATMENT OF LIFE-THREATENING VENTRICULAR TACHYCARDIA


Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: INTRAVENOUS SOTALOL DOSING REGIMEN FOR USE IN A FACILITY THAT CAN PROVIDE ELECTROCARDIOGRAPHIC MONITORING


Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: DOSING REGIMEN FOR INTRAVENOUS SOTALOL FOR ADMINISTRATION IN A FACILITY THAT CAN PROVIDE CONTINUOUS ELECTROCARDIOGRAPHIC MONITORING AND CARDIAC RESUSCITATION.

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rising SOTALOL HYDROCHLORIDE sotalol hydrochloride TABLET;ORAL 075725-004 Dec 19, 2000 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Natco Pharma Usa SOTALOL HYDROCHLORIDE sotalol hydrochloride TABLET;ORAL 075237-003 May 1, 2000 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva SOTALOL HYDROCHLORIDE sotalol hydrochloride TABLET;ORAL 075429-001 May 1, 2000 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs SOTALOL HYDROCHLORIDE sotalol hydrochloride TABLET;ORAL 075238-001 Jul 13, 2000 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm Industries SOTALOL HYDROCHLORIDE sotalol hydrochloride TABLET;ORAL 076576-002 Apr 8, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva SOTALOL HYDROCHLORIDE sotalol hydrochloride TABLET;ORAL 076883-001 Jul 26, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva SOTALOL HYDROCHLORIDE sotalol hydrochloride TABLET;ORAL 075429-004 May 1, 2000 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.